Term ends no later than Oct 27, 2029 · Medium confidence
20-year base term ends Oct 27, 2029
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Oct 27, 2009
Oct 27, 2029
Jul 23, 2019
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 1 of 2 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 27, 2009, when application 12/606,758, the earliest non-provisional in its chain, was filed (this one was filed Mar 18, 2013) | Oct 27, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Oct 27, 2029 | Medium confidence |
This family
| US 8,944,990 | In force Sep 2032 | Sep 2032 |
| US 10,357,284 | this patent no later than Oct 2029 | no later than Oct 2029 |
| US D733,298 | In force Jun 2029 | Jun 2029 |
| US D775,729 | In force Jan 2032 | Jan 2032 |
| US 10,398,431 | In force Aug 2030 | Aug 2030 |
| US 12,310,623 | In force May 2031 | May 2031 |
| Application 19/016,750 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 20, 2014 Reel 32491, frame 440 | Endo Pharmaceuticals Solutions, Inc.; Endo Pharmaceuticals, Inc.; AMS Research Corporation; American Medical Systems, Inc.; Laserscope | Deutsche Bank AG New York Branch, as Collateral Agent | Grant of Security Interest in Patents |
| Aug 28, 2014 Reel 33628, frame 50 | Mujwid, James R.; Hamel, Kory P.; Alexander, James A.; Buysman, John J.; Otte, John F.; Ogdahl, Jason W. | AMS Research Corporation | Assignment of Assignor's Interest |
| Aug 6, 2015 Reel 36285, frame 146 | Deutsche Bank AG New York Branch | American Medical Systems, LLC; AMS Research, LLC; Laserscope | Release of Security Interest |
| Aug 6, 2015 reel/frame not recorded | Deutsche Bank AG New York Branch | American Medical Systems, LLC | Release of Security Interest |
| Aug 6, 2015 reel/frame not recorded | Deutsche Bank AG New York Branch | AMS Research, LLC | Release of Security Interest |
| Aug 6, 2015 reel/frame not recorded | Deutsche Bank AG New York Branch | Laserscope | Release of Security Interest |
| Dec 15, 2015 Reel 37300, frame 199 | AMS Research Corpation | AMS Research, LLC | Change of Name |
| Jan 11, 2016 Reel 37473, frame 745 | AMS Research, LLC | Aphrodite Women's Health, LLC | Assignment of Assignor's Interest |
| Jan 11, 2016 Reel 37473, frame 919 | Aphrodite Women's Health, LLC | Astora Women's Health, LLC | Change of Name |
| Feb 25, 2016 Reel 37916, frame 28 | AMS Research Corporation | AMS Research, LLC | Corrective Assignment to Correct the Conveying Party Data; Previously Recorded on Reel 037300 Frame 0199. Assignor(S) Hereby Confirms the Change of Name. |
| Jun 8, 2017 Reel 42743, frame 278 | Astora Women's Health, LLC | Wilmington Trust, National Association, as Collateral Trustee | Security Interest |
| Sep 7, 2017 Reel 43777, frame 895 | Astora Women's Health, LLC; Endo Health Solutions Inc.; Astora Women's Health Holdings, LLC | Boston Scientific Corporation | Assignment of Assignor's Interest |
| Sep 7, 2017 Reel 43778, frame 167 | Boston Scientific Corporation | Boston Scientific Scimed, Inc. | Assignment of Assignor's Interest |
| Apr 26, 2024 Reel 67240, frame 1 | Wilmington Trust, National Association | Actient Pharmaceuticals LLC; Astora Women’s Health Holdings, LLC; Astora Women’s Health LLC; Auxilium Pharmaceuticals, LLC; Auxilium US Holdings, LLC; BioSpecifics Technologies Corp.; BioSpecifics Technologies LLC; Dava International, LLC; Dava Pharmaceuticals, LLC; Endo Generic Holdings, Inc. (Formerly Known as Par Pharmaceuticals Companies, Inc.); Endo Pharmaceuticals Inc.; Endo Pharmaceuticals Solutions Inc. (Formerly Known as Indevus Pharmaceuticals, Inc.); Generics Bidco I, LLC; Generics International (US), Inc.; Par Pharmaceutical, Inc.; Par Sterile Products, LLC (Formerly Known as JHP Pharmaceuticals, LLC); Quartz Specialty Pharmaceuticals, LLC; Slate Pharmaceuticals, LLC; Vintage Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Actient Pharmaceuticals LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Astora Women’s Health Holdings, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Astora Women’s Health LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium US Holdings, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies Corp. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava International, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Generic Holdings, Inc. (Formerly Known as Par Pharmaceuticals Companies, Inc.) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Solutions Inc. (Formerly Known as Indevus Pharmaceuticals, Inc.) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics Bidco I, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics International (US), Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Pharmaceutical, Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Sterile Products, LLC (Formerly Known as JHP Pharmaceuticals, LLC) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Quartz Specialty Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Slate Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Vintage Pharmaceuticals, LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Oct 27, 2029. We will not guess the cap.